Ana Anderson, PhD is an associate professor of neurology at Harvard Medical School, associate scientist at Brigham and Women’s Hospital, an associate member of the Broad Institute, and a core faculty member of the Evergrande Center for Immunologic Disease. She has deep expertise in both autoimmunity and cancer immunology – two core areas of focus for Compass Therapeutics. Her most recent immunology work is on inhibitory molecules and how they regulate T cell response to tumors. Prior to her work on cancer, she published groundbreaking research on T cell cross-reactivity in autoimmunity. Ana is on the editorial board for OncoImmunology, Cellular Immunology, and Journal for Immunotherapy of Cancer.

Ana earned her PhD from Harvard University. During her PhD, she was awarded a fellowship from the Howard Hughes Medical Institute.